A PARI inhaler and a smartphone displaying breathing instructions are overlaid with digital data, molecular structures, and abstract blue patterns.

Usability & Adherence:

Key to Clinical and Commercial Success

 

The success of the inhaled therapy is highly dependent on correct device use, patient motivation and therapy adherence. eFlow® Technology nebulizers together with the PARI Connect Platform are designed to improve inhalation treatments. With a forward-looking approach our in-house human factors engineering team performs and supports usability studies.

Expert Interviews:

Hear from our experts regarding device usability and our digital solutions with the aim of increasing therapy adherence.

Usability

    

Digital Solutions

            

A hand holds a white and gray eFlow Integrated inhaler against a dark blue background.

 

State-of-the-art Nebulizer Usability

Discover how human factor studies shaped our new eFlow Integrated device platform from the very beginning to increase patient adherence.

Learn more

How eFlow® Technology Enhances Patient Adherence in Clinical Studies and Commercialization

    • Reduced treatment time through short nebulization time
    • Patient-centric device design and easy assembly for increased acceptance
    • PARI Connect® App for better therapy outcomes – proven enhancement of therapy adherence as well as motivation of patients in day-to-day use

    Want to Optimize Patient Adherence?

    eFlow-partneringpari.com

    PARI Business Development Team